A randomized controlled study on the application of multi-channel non-pipette sealed infusion connectors in intravenous therapy

A randomized controlled study on the application of multi-channel non-pipette sealed infusion connectors in intravenous therapy.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2600127691

Enrollment

Unknown

Registered

2026-07-06

Start date

2026-07-12

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phlebitis, extravasation during infusion, bleeding from the needle puncture site, inflammation of the surrounding skin

Interventions

Control group:Administering intravenous infusion using an infusion connector

Treatment group:Administering intravenous infusion using multi-channel non-pipette sealed infusion connectors

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18 - 80 years old. Gender: Open to all. 2. Due to the need of the condition (such as chemotherapy, nutritional support, multi-drug combination therapy, etc.), multi-channel intravenous infusion treatment is required. It is estimated that the usage time of multi-channel connection devices will be >= 48 hours. 3. Those who agree to participate in this trial and sign the informed consent form. 4. Has not participated in any other medical device clinical trials in the past month.

Exclusion criteria

Exclusion criteria: 1. Those with infections, ulcers, thrombosis or vascular diseases (such as severe arteriosclerosis) at the puncture site are not suitable for venous catheterization. 2. Patients with a puncture-induced axillary temperature exceeding 38?. 3. For those who are allergic to research equipment. 4. Pregnant and lactating women. 5. Mental disorders, cognitive dysfunction or those who are unable to cooperate and complete the assessment. 6. The researchers considered other circumstances that were not suitable for participation in this study (such as refusing to cooperate with the treatment, frequent transfers to other departments, etc.).

Design outcomes

Primary

Measure	Time frame
Single-time multi-path connection operation time;	—

Secondary

Measure	Time frame
Researcher operational satisfaction score;Liquid leakage rate;vital signs;The incidence rate of phlebitis;Incidence of adverse events;	—

Countries

China

Contacts

Public ContactZhang Yun

Gansu Provincial Maternity and Child-care Hospital

11974140@qq.com+86 931 5188792

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026